Therapeutic effect of gedatolisib, a pan-PI3K/mTOR inhibitor, on prostate cancer models with PI3K or PTEN mutational status von Sen, Adrish, Khan, Salmaan A, MacNeil, Ian A., Rich, Benjamin E., Molden, Jhomary S, Davis, Laura N, Rossetti, Stefano, Broege, Aaron M, Laing, Lance G.

Volltext

Loss of the nutrient sensor TAS1R3 leads to reduced bone resorption von Eaton, Michael S., Weinstein, Nicholas, Newby, Jordan B., Plattes, Maggie M., Foster, Hanna E., Arthur, Jon W., Ward, Taylor D., Shively, Stephen R., Shor, Ryann, Nathan, Justin, Davis, Hannah M., Plotkin, Lilian I., Wauson, Eric M., Dewar, Brian J., Broege, Aaron, Lowery, Jonathan W.

Volltext